Go to content
- {{#headlines}}
- {{title}} {{/headlines}}
Profile
| Academic position | Currently without academic position |
|---|---|
| Research fields | Physiology,Cell Biology |
| Keywords | liver tumor, inhibitor, ferroptosis suppressor protein 1, ferroptosis, cancer therapy |
Current contact address
| Country | People's Republic of China |
|---|---|
| City | Nanjing |
| Institution | Nanjing University |
Host during sponsorship
| Dr. Marcus Conrad | Institut für Metabolismus und Zelltod, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Oberschleißheim |
|---|---|
| Start of initial sponsorship | 01/03/2021 |
Program(s)
| 2020 | Humboldt Research Fellowship Programme for Postdocs |
|---|
Publications (partial selection)
| 2021 | Zheng, Jiashuo and Sato, Mami and Mishima, Eikan and Sato, Hideyo and Proneth, Bettina and Conrad, Marcus: Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. In: Cell Death \& Disease, 12, 2021, 1--10 |
|---|